High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients

Journal of Hypertension

Volumn 21, Issue 11, 2003, Pages 2149-2157

  Stowasser, Michael ^a   Gordon, Richard D ^a   Gunasekera, Thanuja G ^a   Cowley, Diane C ^a   Ward, Gregory ^a   Archibald, Colin ^a   Smithers, B Mark ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adrenal venous sampling; Aldosterone producing adenoma; Aldosterone:renin ratio; Bilateral adrenal hyperplasia; Diagnosis; Hyperaldosteronism; Prevalence; Primary aldosteronism; Screening; Treatment

Indexed keywords

ALDOSTERONE; AMILORIDE; FLUDROCORTISONE; GLUCOCORTICOID; RENIN; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENAL SUPPRESSION; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; ARTICLE; BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FEMALE; GENETIC ANALYSIS; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SCREENING; VENOUS BLOOD;

EID: 0346694511     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200311000-00025     Document Type: Article

References (32)

1. Gordon RD, Klemm SA, Tunny TJ, Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet 1992; 340:159-161.
2. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary aldosteronism: a missed diagnosis in 'essential hypertensives'? Aust NZ J Med 1996; 26:533-538.
3. Young WF Jr. Primary aldosteronism: update on diagnosis and treatment. Endocrinologist 1997; 7:213-221.
4. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14:311-315.
5. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85:2854-2859.
6. Rayner BL, Opie LH, Davidson JS. The aldosterone/renin ratio as a screening test for primary aldosteronism. South African Med J 2000; 90:394-400.
7. Fardella CE, Mosso L, Gomez-Sanchez CE, Cortez P, Soto J, Gomez L, et al. Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 2000; 85:1863-1867.
8. Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 2000; 54 (suppl 1):83S-85S.
9. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37:699-705.
10. Schwartz GL, Turner ST. Predictive value of the aldosterone-renin ratio in screening for primary aldosteronism. Am J Hypertens 2002; 15:266A.
11. Hood S, Cannon J, Scanlon M, Brown MJ. Prevalence of primary hyperaldosteronism measured by aldosterone to renin ratio and spironolactone testing: PHARST study. J Hypertens 2002; 20 (suppl 4):S119.
12. Calhoun DA, Nishizaka MK, Weissman P, Zaman MA, Thakkar RB. High prevalence of primary aldosteronism among black and white subjects with resistant hypertension. J Hypertens 2002; 20 (suppl 4):S122.
13. Biglieri EG, Kater CE. Disorders of the adrenal cortex. In: Stein JH (editor): Internal medicine, 3rd ed. Boston, MA: Little, Brown; 1991, pp. 2188-2207.
14. Kaplan NM. Clinical hypertension, 6th ed. Baltimore: Williams and Wilkins; 1994, pp. 389-408.
15. Stowasser M. How common is adrenal-based mineralocorticoid hypertension? Curr Opin Endocrinol Diab 2000; 7:143-150.
16. Rutherford JC, Taylor WL, Stowasser M, Gordon R. Success of surgery in primary aldosteronism judged by residual autonomous aldosterone production. World J Surg 1998; 22:1243-1245.
17. Kaplan NM. Cautions over the current epidemic of primary aldosteronism. Lancet 2001; 357:953-954.
18. Padfield PL. Primary aldosteronism, a common entity? The myth persists. J Hum Hypertens 2002; 16:159-162.
19. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD (editor): Textbook of hypertension. London: Blackwell Scientific; 1994, pp. 865-892.
20. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2:156-169.
21. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Comm 1995; 207: 565-571.
22. Stowasser M. Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Reports 2001; 3:230-239.
23. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-717.
24. Vetter H, Siebenschein R, Studer A, Witassek F, Furrer J, Glanzer K, set al. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone. Acta Endocrinol 1978; 89:710-725.
25. Jeck T, Weisser B, Mengden T, Erdmenger L, Grune S, Vetter W. Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands. Clin Invest 1994; 72:979-984.
26. Gordon RD. Diagnostic investigations in primary aldosteronism. In: Zanchetti A (editor): Clinical medicine series on hypertension. London: McGraw-Hill International; 2001, pp. 101-114.
27. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40:897-902.
28. Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens 1987; 5 (suppl 5):S103-S106.
29. Gordon RD, Rutherford JC, Stowasser M. Primary aldosteronism: are we diagnosing and operating on too few patients? World J Surg 2001; 25:941-947.
30. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001; 86:1083-1090.
31. Nishikawa T, Omura M, Ito H, Saito J. Prevalence of primary aldosteronism among Japanese hypertensive patients. J Hypertens 2002; 20 (suppl 4):S172.
32. McAlister FA, Lewanczuk RZ. Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiological testing before adrenalectomy. Can J Surg 1998; 41:299-305.